Clinical trial
Cognitive/Cerebrovascular Consequences of HTN Treatment
NCT00151138 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00151138 |
|---|---|
| Title | Cognitive/Cerebrovascular Consequences of HTN Treatment |
| Official title | Cognitive and Cerebrovascular Sequelae of Hypertension |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Atenolol (drug), Lisinopril (drug) |
| Enrollment | 50 |
| Start date | Sep 1, 2002 |
| Completion | May 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Dec 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: